FDA
-
-
-
-
-
-
-
Connect Biopharma completes enrollment in Phase 2 asthma drug study
-
-
-
-
-
-
-
Connect Biopharma reports positive Phase 3 atopic dermatitis results
-
-
-
-
-
-
-
Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight
-
-
-
-
-
-
-
Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025
-
-
-
-
-
-
-
Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors
-
-
-
-
-
-
-
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
-
-
-
-
-
-
-
Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference
-
332,018 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

